Abstract:Objective: To evaluate the role of diffusion-weighted MRI in differentiating benign from malignant primary bone tumors. To know the sensitivity and specificity of diffusion weighted MRI and calculating apparent diffusion coefficient (ADC) cutoff in differentiating benign from malignant primary bone tumors. Methods and materials : This is a prospective observational study of 50 patients, who were clinically or radiologically suspected with primary bone tumor and referred to the Department of Radiodiagnosis, for radiography or for MRI. These patients underwent routine MRI sequences including diffusion-weighted MRI with b-values of 0, 500 and 1000, followed by pathological examination supplemented by immunohistochemistry (wherever necessary). Hematological malignancies, recently biopsied cases and recurrent cases were excluded from the study. Results: Out of 50 patients with suspected bone tumors, 15 were benign (and tumor like lesions) and 35 were malignant primary bone tumors. The most common age group involved for both benign and malignant primary bone tumors was 11–20 years (23 cases—46%). In our study, total number of affected males were 27 (54%) and total number of affected females were 23 (46%) with M:F ratio of 1.17:1. In this study 72% lesions had appendicular bone involvement and 28% had axial bone involvement. 94.3% of malignant lesions showed restriction on diffusion-weighted imaging (DWI) and in 80 % of benign lesions restriction was absent on DWI which was statistically significant. Mean ADC levels in malignant lesions was 1.092 ± 0.497 and in benign lesions was 1.62 ± 0.596 which was statistically significant. Chondrosarcoma had highest ADC and Ewing’s sarcoma had lowest ADC values in malignant lesions. Chondroblastoma had highest ADC and Osteomyelitis had lowest ADC values in benign lesions. ADC value of 1.31 had highest sensitivity and specificity to differentiate between benign and malignant lesions. Conclusion: DWI is helpful in differentiating malignant from benign bone tumors and tumor like lesions with diffusion restriction favoring malignancy. Inspite of some overlap, ADC values of benign and malignant bone tumors are different and measurement of ADC values improves the accuracy of the diagnosis of bone tumors and tumor like lesions. Calculation of ADC may also be used as baseline reference to assess response to treatment in future or for follow up. Advances in knowledge: DWI imaging (and ADC values) has been extensively used in neuroimaging. Extension of this application to musculoskeletal–oncologic imaging is not so well studied. Apart from differentiating benign from malignant lesions which is the main focus of this study, assessment of response to treatment by ADC values may be possible in near future.

Value of Apparent Diffusion Coefficient in MR Diffusion-Weighted Imaging for Differential Diagnosis of Benign and Malignant Musculoskeletal Tumors

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

Role of apparent diffusion coefficients with diffusion-weighted magnetic resonance imaging in differentiating between benign and malignant bone tumors

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Role of diffusion-weighted MRI in differentiating benign from malignant bone tumors

Value of MRI in-phase and opposed-phase,apparent diffusion coefficient and diffusion-weighted imaging in distinguishing benign and malignant spinal lesions

Diagnostic Performance of Diffusion MRI for differentiating Benign and Malignant Nonfatty Musculoskeletal Soft Tissue Tumors: A Systematic Review and Meta-analysis

Correlating Apparent Diffusion Coefficients with Histopathologic Findings on Meningiomas

Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading

Differentiation of benign and malignant lesions of the prostate by MR diffusion weighted imaging

Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors

MR diffusion-weighted imaging in differential diagnosis of breast lesions with different enhancement shapes or size and parameter selection

Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI

Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging

DWI and ADC Value in Differential Diagnosis of Brain Tumors

Diagnosis value of apparent diffusion coefficient of magnetic resonance imaging in grading of prostate cancer

Initial Study of Diagnostic Value in Diffusion Weighted Imaging of Breast Neoplasm

Diagnostic Value of Diffusion Weighted Imaging for Breast Lesions at 3.0T MR

Differentiation of Clinically Benign and Malignant Breast Lesions Using Diffusion-Weighted Imaging

The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors

Value of Diffusion-weighted Imaging with Different b Values in the Diagnosis of Breast Lesions at 3.0T MRI